Summary of Key Points Core Viewpoint - Suzhou Ruikeda Connection System Co., Ltd. has successfully issued convertible bonds amounting to RMB 1 billion, with a net amount of RMB 988.85 million after deducting issuance costs, and has established a special account for the management of these funds [2][3][4]. Group 1: Fundraising Details - The company issued 10 million convertible bonds with a face value of RMB 100 each, for a total of RMB 1 billion, with a maturity of 6 years [2]. - The actual net amount raised after deducting issuance costs of RMB 11.15 million is RMB 988.85 million, which was verified by a certified public accountant [2]. Group 2: Special Account and Agreement - The company has opened a special account for the management of the raised funds, authorized by the board of directors, to ensure proper storage and usage of the funds [3][4]. - A tripartite supervision agreement has been signed among the company, the underwriter Dongwu Securities, and the banks holding the funds to regulate the management and usage of the raised funds [4][5]. Group 3: Key Provisions of the Tripartite Agreement - The special account is exclusively for the storage and use of funds raised from the convertible bond issuance, specifically for designated projects [6][12]. - The underwriter is responsible for supervising the usage of the funds and must conduct semi-annual inspections of the fund management [8][13]. - Any withdrawal exceeding 20% of the net amount raised must be reported to the underwriter, ensuring transparency in fund usage [9][22].

登录新浪财经APP 搜索【信披】查看更多考评等级 关于未能按期归还暂时补充流动资金的闲置 募集资金的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要事项： ● 根据前期临时债委会协议，公司需在最长不超过6个月内，即2025年11月8日前完成24,000万元前期暂 时补流的募集资金归还，如未能按时归还，临时债委会将表决继续存续或就地解散。截至本公告披露 日，临时债委会前期约定的期限已满，公司尚未将该笔24,000万元暂时补充流动资金的闲置募集资金归 还至募集资金专用账户。 ● 近日，临时债委会召开了临时债委会工作会议，各债权行于会议中现场表决，同意临时债委会继续存 续。本次临时债委会延续6个月，自2025年11月8日至2026年5月7日。截至目前，《临时债委会协议》补 充协议尚未正式签署完毕，具体以最终签署的补充协议为准。敬请广大投资者注意投资风险。 一、未能按期归还暂时补充流动资金的闲置募集资金事项概述 苏州瀚川智能科技股份有限公司（以下简称"公司"或"瀚川智能"）于2023年1月9日收到中国证券监督管 理委 ...

Fundraising Overview - The company successfully completed its initial public offering (IPO) by issuing 17,543,860 shares at a price of RMB 106.19 per share, raising a total of RMB 186,298.25 million, with a net amount of RMB 174,219.58 million after deducting issuance costs [2][3] Fund Management and Usage - The company has established a special account for the raised funds, which is solely designated for the R&D center construction project and other related projects, ensuring that the funds are not used for any other purposes [6][20] - The balance in the special account as of November 11, 2025, is RMB 31,244.82 million, with additional accounts holding balances of RMB 8,000 million and RMB 9,972.27 million [11][15][20] Regulatory Compliance - The company has signed a tripartite supervision agreement with its wholly-owned subsidiary and the underwriting institution to ensure compliance with relevant laws and regulations, protecting investors' rights [4][26] - The underwriting institution is responsible for ongoing supervision of the fund usage, including conducting on-site investigations and providing regular account statements [7][27] Changes in Project Implementation - The company has approved changes to the implementation location of the R&D center project and has authorized the use of part of the raised funds for capital increase in its wholly-owned subsidiary to facilitate the project [3][30]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001400 证券简称：江顺科技 公告编号：2025-047 江苏江顺精密科技集团股份有限公司 关于新增募集资金专户并签订募集资金监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意江苏江顺精密科技集团股份有限公司首次公开发行股票注册的批 复》（证监许可〔2025〕608号）同意注册，并经深圳证券交易所《关于江苏江顺精密科技集团股份有 限公司人民币普通股股票上市的通知》（深证上〔2025〕364号）同意，江苏江顺精密科技集团股份有 限公司（以下简称"公司"）已向社会公众公开发行人民币普通股（A股）股票1,500万股，发行价格为每 股人民币37.36元，募集资金总额为人民币560,400,000.00元，扣除与发行有关的费用人民币 69,930,292.50元（不含增值税）后，实际募集资金净额为490,469,707.50元。 截至2025年4月21日，公司上述募集资金净额已全部到位，立信中联会计师事务所（特殊普通合伙）对 本次发行募集 ...

节余募集资金的公告 登录新浪财经APP 搜索【信披】查看更多考评等级 《股东会议事规则》中"股东大会"统一修改为"股东会"，"或"统一修改为"或者"，"大会主持人"统一修 改为"会议主持人"，为阅读方便，不再逐一对照列示；除上述修订的条款外，同时删除第四至第六条、 第八条、第十条、第十三条、第十七至第二十一条、第二十六至二十八条、第三十一条、第三十二条、 第四十条至第四十二条、第四十四条、第五十二条、第五十四条、第五十五条、第五十七条、第五十九 条、第九至十章（第六十七至第七十二条）。本次修订后的股东会议事规则共六章五十七条。 3.董事会议事规则修订对比表 ■ 《董事会议事规则》中"股东大会"统一修改为"股东会"，为阅读方便，不再逐一对照列示；除上述修订 的条款外，其他条款保持不变。 证券代码：600353 证券简称：旭光电子 公告编号：2025-056 成都旭光电子股份有限公司 关于募集资金投资项目结项并使用 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次结项的募投项目名称：2022年度非公开发行A ...

Core Points - Wuhan Heyuan Biotechnology Co., Ltd. has approved the use of raised funds to replace self-raised funds previously invested in fundraising projects and to cover issuance expenses [2][6] - The total amount of raised funds is approximately RMB 2.6 billion, with a net amount of approximately RMB 2.43 billion after deducting issuance expenses [12][2] - The company plans to use RMB 469.56 million to replace self-raised funds for investment projects and RMB 5.19 million for issuance expenses [4][5] Fundraising Overview - The company issued 89,451,354 shares at a price of RMB 29.06 per share, raising a total of RMB 2,599,456,347.24 [12][2] - After deducting issuance expenses of RMB 169,031,770.68, the net amount raised is RMB 2,430,424,576.56 [12][2] - All raised funds are managed in a special account, with a tripartite supervision agreement in place [3] Investment Project Details - The company has pre-invested RMB 469,556,343.17 in fundraising projects using self-raised funds [4] - The issuance expenses totaled RMB 169,031,770.68, with RMB 5,187,028.30 already paid from self-raised funds [5] Approval Process - The board of directors approved the use of raised funds for replacement at a meeting held on November 21, 2025 [6] - The replacement of funds is compliant with relevant regulations and does not require shareholder approval [6][7] Cash Management Plan - The company plans to manage temporarily idle raised funds (including oversubscription funds) to enhance fund utilization efficiency [9][10] - The cash management will involve purchasing safe, liquid, principal-protected products, with a limit of RMB 2.1 billion [13][10] - The cash management period is valid for 12 months from the board's approval date [13][14] Risk Management - The company will select reputable financial institutions for cash management products and will monitor investment risks closely [19][20] - Independent directors and the audit committee will oversee the use of funds [20][21] Impact on Company Operations - The cash management initiative is designed to improve fund efficiency without affecting ongoing investment projects [23] - The company aims to generate additional returns for itself and its shareholders through this cash management strategy [23][25]

证券代码：688502 证券简称：茂莱光学 公告编号：2025-087 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 南京茂莱光学科技股份有限公司 关于部分募集资金专户注销的公告 南京茂莱光学科技股份有限公司（以下简称"公司"）首次公开发行股票募集资金按照相关法律法规和规 范性文件的规定在银行开立了募集资金专项账户。近日，公司办理完成部分募集资金专项账户的注销手 续，现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会于2023年1月12日出具的《关于同意南京茂莱光学科技股份有限公司首次 公开发行股票注册的批复》（证监许可〔2023〕84号），公司向社会公开发行人民币普通股1,320万 股，每股发行价格为人民币69.72元，募集资金总额为人民币92,030.40万元；扣除发行费用后实际募集 资金净额为人民币81,134.18万元。 上述资金已全部到位，经中天运会计师事务所（特殊普通合伙）审验并于2023年3月2日出具了中天运 〔2023〕验字第90012号《验资报告》。公司已对上述募集资金进行了专户存 ...

Core Viewpoint - The company has approved the continued use of raised funds to purchase financial products or structured deposits, aiming to enhance fund utilization efficiency while ensuring that it does not affect the construction of investment projects or the use of raised funds [2][14]. Summary by Sections Fundraising Overview - The company raised a total of 1,315,319,983.02 RMB through a non-public offering of 115,076,114 shares at a price of 11.43 RMB per share, with a net amount of 1,303,670,100.75 RMB after deducting various fees [2][4]. Fund Management - The company has established a special account for the management and storage of raised funds, ensuring that all funds are deposited in a board-approved special account and are subject to regulatory agreements with the sponsoring institution and the commercial bank [3]. Investment Projects - The company has adjusted its investment projects, reallocating funds from the "Health Industry Expansion Project" to invest 45,800.58 million RMB in the "Traditional Chinese Medicine Production Base Construction Project" [5]. Cash Management - The company plans to use up to 850 million RMB of idle raised funds for purchasing safe, liquid financial products or structured deposits with a capital preservation commitment, with the authority to make investment decisions granted to the chairman or CFO [10][14]. Risk Control Measures - The company will select financial products from issuers that can provide capital preservation guarantees, ensuring high safety and liquidity, and will not affect the normal operation of the investment projects [15][17]. Approval Process - The decision to continue using idle raised funds for financial products was approved by the board's audit committee and the board of directors, confirming compliance with relevant regulations and ensuring that it aligns with the interests of the company and its shareholders [13][18].

Group 1 - The company completed the cancellation of its fundraising special account as part of its financial management strategy [4] - The company raised a total of RMB 383,714,880.00 through a non-public offering of 88,008,000 shares at RMB 4.36 per share, with a net amount of RMB 376,615,860.47 after deducting fees [2][3] - The company established a special account for the management of the raised funds, in compliance with relevant laws and regulations [2][3] Group 2 - The company approved the conclusion of several fundraising projects and decided to permanently supplement its working capital with the remaining funds [3][4] - The special account for the "Beihai Chengde Nickel Industry 132+180 Sintering Denitrification EPC Project" has been closed, and the remaining funds were transferred to the company's own account [4] - The agreements related to the special account management with the sponsor and banks have been terminated following the account closure [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600292 证券简称：远达环保 编号：临2025－078号 国家电投集团远达环保股份有限公司 第十届董事会第三十五次（临时）会议 决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的 真实性、准确性和完整性承担个别及连带责任。 国家电投集团远达环保股份有限公司第十届董事会第三十五次（临时）会议通知于2025年11月16日以邮 件方式发出，会议于2025年11月21日10:00在公司12楼会议室召开，应到董事11人，实到董事8人，委托 出席3人（副董事长苏琦、董事姚小彦因公出差书面委托董事长陈斌，董事刘向杰因公出差书面委托董 事吴连成）；高管3人列席了会议。会议的召集、召开程序符合《中华人民共和国公司法》等法律法 规、规章、规范性文件和《公司章程》的有关规定。会议由公司董事长陈斌先生主持，经董事认真审议 及表决，全体与会董事一致通过了如下决议： 表决结果：赞成6票，反对0票，弃权0票，回避5票,关联方国家电投集团派出董事全部回避表决。 表决结果：赞成11票，反对0票，弃权0票，回避0票。 该事项详见公司 ...